Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 1Hypertension 1

Interventions

ziprasidone 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Urine Specimen Collection 1Tranexamic Acid 1Tobramycin 1Sunitinib 1Standard of Care 1Spironolactone 1Sevelamer 1Rocuronium 1Polymorphism, Genetic 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Nifedipine 1Nafcillin 1Molindone 1Methylprednisolone 1Lurasidone Hydrochloride 1Labetalol 1Hydrochlorothiazide 1Haloperidol 1Gastrectomy 1Fosfomycin 1Endoscopic Mucosal Resection 1Electrocardiography 1Clozapine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Hypertension × Hydrochlorothiazide × Clear all
NCT04334824 2024-09-19

Hydrochlorothiazide and Risk of Skin Cancer

Canadian Network for Observational Drug Effect Studies, CNODES

Completed
2,953,748 enrolled
Dermatologic

Hypertension, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡